Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Syneos Health® announced a strategic multi-year agreement with Microsoft. Utilizing Microsoft Azure services, Syneos Health has developed an advanced analytics platform that enables agile deployment of machine learning (ML) supporting the analysis, ...
read more
Thursday, December 10, 2020
Syneos Health has completed the previously announced acquisition of Synteract, a CRO focused on the biopharma segment.
read more
Friday, December 16, 2022
Syneos Health® announced it has extended its strategic partnership with Medable as part of the Company’s commitment to bring clinical trials closer to the patient.
read more
Syneos Health® has expanded its relationship with Komodo Health.
read more
Wednesday, January 09, 2019
Syneos Health announced the appointment of Paul Colvin as President, Clinical Solutions. Colvin joins Syneos Health from Pharmaceutical Product Development (PPD).
read more
Syneos Health® and Medable have announced a strategic partnership to bring clinical trials closer to the patient.
read more
Syneos Health® has signed a new three-year agreement with Pfizer to deliver global product development solutions to support Pfizer's portfolio.
read more
Monday, November 02, 2020
Syneos Health announced an agreement to acquire Synteract, a full-service CRO focused on the biopharma segment.
read more
Wednesday, August 02, 2023
Syneos Health announced that the company’s stockholders approved an agreement to take the company private through an acquisition by a consortium of private investment firm affiliates comprised of Elliott Investment Management L.P., Patient Square ...
read more
Tuesday, November 12, 2019
Syneos Health and AiCure announced a novel strategic partnership to drive trials to optimize patient engagement.
read more
Wednesday, December 16, 2020
Syneos Health and ConcertAI have announced a strategic collaboration to accelerate and streamline the implementation of novel oncology clinical trial research and study designs.
read more
Syneos Health and Elligo Health Research are entering a strategic collaboration to mobilize a system of accelerated research to reach real-world patients.
read more
Wednesday, February 02, 2022
Syner-G BioPharma Group announced the acquisition of Impact Pharmaceutical Services. Based in Research Triangle Park, NC, IMPACT supports the outsourced medical writing, regulatory strategy, and regulatory publishing and submission needs of biotech ...
read more
Wednesday, February 27, 2019
Synergy confirmed that the previously announced agreement with Bausch Health Companies has been designated as the highest and best offer for Synergy's assets, including all rights to TRULANCE®.
read more
Synergy Pharmaceuticals has entered into a license agreement with Luoxin Pharmaceutical.
read more